Cargando…

An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors

PURPOSE: Inspired by the hypothesis that heterogeneity in the biology of breast cancers at the cellular level may account for cognitive dysfunction symptom variability in survivors, the current study explored relationships between host single-nucleotide polymorphisms (SNPs) in 25 breast cancer-relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koleck, Theresa A, Bender, Catherine M, Clark, Beth Z, Ryan, Christopher M, Ghotkar, Puja, Brufsky, Adam, McAuliffe, Priscilla F, Rastogi, Priya, Sereika, Susan M, Conley, Yvette P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344452/ https://www.ncbi.nlm.nih.gov/pubmed/28424560 http://dx.doi.org/10.2147/BCTT.S123785

Ejemplares similares

Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory study
por: Koleck, Theresa A., et al.
Publicado: (2016)

Associations between pathologic tumor features and preadjuvant therapy cognitive performance in women diagnosed with breast cancer
por: Koleck, Theresa A., et al.
Publicado: (2017)

Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level
por: Koleck, Theresa A, et al.
Publicado: (2016)

Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors
por: Wagner, Monica A., et al.
Publicado: (2023)

Factors associated with sleep disturbances in women undergoing treatment for early-stage breast cancer
por: Grayson, Susan, et al.
Publicado: (2021)

Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive seed localization
por: Clark, Beth Z., et al.
Publicado: (2023)

The Influence of Physical Activity and Epigenomics On Cognitive Function and Brain Health in Breast Cancer
por: Wagner, Monica A., et al.
Publicado: (2020)

Artificial intelligence-directed prognostication of breast cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2019)

Women's experiences of gestational breast cancer and their interactions with the healthcare system: A scoping review
por: Hurren, Sara, et al.
Publicado: (2022)

Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study
por: Menekse, Ebru, et al.
Publicado: (2015)

Current Approaches and Emerging Directions in HER2-resistant Breast Cancer
por: Brufsky, Adam M
Publicado: (2014)

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors
por: Miaskowski, Christine, et al.
Publicado: (2019)

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
por: Carleton, Neil, et al.
Publicado: (2022)

Statins and endocrine resistance in breast cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer
por: Carleton, Neil, et al.
Publicado: (2021)

Symptom Experience, Management, and Outcomes According to Race and Social Determinants Including Genomics, Epigenomics, and Metabolomics (SEMOARS + GEM): an Explanatory Model for Breast Cancer Treatment Disparity
por: McCall, Maura K., et al.
Publicado: (2019)

nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings
por: Brufsky, Adam
Publicado: (2017)

Methylation Data Processing Protocol and Comparison of Blood and Cerebral Spinal Fluid Following Aneurysmal Subarachnoid Hemorrhage
por: Arockiaraj, Annie I., et al.
Publicado: (2020)

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer
por: Brufsky, Adam M.
Publicado: (2014)

Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
por: Gazet, J. C., et al.
Publicado: (1996)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008)

Expanded criteria for pretreatment staging CT in breast cancer
por: Roszkowski, N, et al.
Publicado: (2021)

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer
por: Brufsky, Adam M.
Publicado: (2015)

Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions
por: Hough, Bruce, et al.
Publicado: (2010)

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Patient preferences for chemotherapies used in breast cancer
por: Beusterien, Kathleen, et al.
Publicado: (2012)

Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy
por: Kober, Kord M, et al.
Publicado: (2019)

The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer
por: Bhargava, Rohit, et al.
Publicado: (2020)

Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER
por: Yardley, D A, et al.
Publicado: (2014)

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?
por: Steinman, Richard A, et al.
Publicado: (2012)

Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
por: Stravodimou, Athina, et al.
Publicado: (2013)

Statin drugs to reduce breast cancer recurrence and mortality
por: Beckwitt, Colin H., et al.
Publicado: (2018)

Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women’s Health Initiative
por: Park, Na-Jin, et al.
Publicado: (2017)

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
por: Berruti, A, et al.
Publicado: (2005)

Older Breast Cancer Survivors’ Cognitive Response to Qigong/Tai Chi Easy: An Exploratory Analysis
por: James, Dara, et al.
Publicado: (2021)

How do health and allied health practitioners perceive excellence in residential aged care? An exploratory qualitative study
por: Cameron, Nadine, et al.
Publicado: (2022)

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy
por: Leone, José Pablo, et al.
Publicado: (2015)

The value of immunotherapy for survivors of stage IV non-small cell lung cancer: patient perspectives on quality of life
por: Park, Rebekah, et al.
Publicado: (2020)

Breast cancer mortality as a function of age
por: Nasrazadani, Azadeh, et al.
Publicado: (2022)

Symptom Cluster Research in Women with Breast Cancer: A Comparison of Three Subgrouping Techniques()
por: Starkweather, Angela R., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ro5o0faget8itm0f3lirhcrhi9